OrbiMed

OrbiMed

OrbiMed

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will he
Founded
1989
Follow us
Alexa global traffic share
Latest investments Show all
$80,000,000
Venture capital (Series B)
ReCode Therapeutics
$91,000,000
Post-IPO equity
Alpine Immune Sciences
Team Size
50+
Employees
Geographical Focus
Past year's investments
  • 6 rounds in the past year
  • $451M deployed in total
  • $75.2M avg per round
Latest rounds
  • ReCode Therapeutics: Venture capital (Series B) ($80M)
  • Alpine Immune Sciences: Post-IPO equity ($91M)
  • iECURE: Venture capital (Series A) ($50M)